Nianjun Liu1, Marguerite R Irvin2, Degui Zhi3, Amit Patki4, T Mark Beasley4, Deborah A Nickerson5, Charles E Hill6, Jinbo Chen7, Stephen E Kimmel7,8, Nita A Limdi9. 1. Department of Epidemiology & Biostatistics, School of Public Health - Bloomington, Indiana University, Bloomington, IN 47405, USA. 2. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA. 3. School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX 77030, USA. 4. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA. 5. Department of Genome Sciences, School of Medicine, University of Washington, Seattle, WA 98195, USA. 6. Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. 7. Department of Biostatistics & Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 8. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 9. Department of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Abstract
AIM: We conducted a genome-wide association study using the Illumina Exome Array to identify coding SNPs that may explain additional warfarin dose variability. PATIENTS & METHODS: Analysis was performed after adjustment for clinical variables and genetic factors known to influence warfarin dose among 1680 warfarin users (838 European-Americans and 842 African-Americans). Replication was performed in an independent sample. RESULTS: We confirmed the influence of known genetic variants on warfarin dose variability. Our study is the first to show the association between rs12772169 and warfarin dose in African-Americans. In addition, genes COX15 and FGF5 showed significant association in European-Americans. CONCLUSION: We identified some novel genes/SNPs that underpin warfarin dose response. Further replication is needed to confirm our findings.
AIM: We conducted a genome-wide association study using the Illumina Exome Array to identify coding SNPs that may explain additional warfarin dose variability. PATIENTS & METHODS: Analysis was performed after adjustment for clinical variables and genetic factors known to influence warfarin dose among 1680 warfarin users (838 European-Americans and 842 African-Americans). Replication was performed in an independent sample. RESULTS: We confirmed the influence of known genetic variants on warfarin dose variability. Our study is the first to show the association between rs12772169 and warfarin dose in African-Americans. In addition, genes COX15 and FGF5 showed significant association in European-Americans. CONCLUSION: We identified some novel genes/SNPs that underpin warfarin dose response. Further replication is needed to confirm our findings.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Elisabeth Mangold; Kerstin U Ludwig; Stefanie Birnbaum; Carlotta Baluardo; Melissa Ferrian; Stefan Herms; Heiko Reutter; Nilma Almeida de Assis; Taofik Al Chawa; Manuel Mattheisen; Michael Steffens; Sandra Barth; Nadine Kluck; Anna Paul; Jessica Becker; Carola Lauster; Gül Schmidt; Bert Braumann; Martin Scheer; Rudolf H Reich; Alexander Hemprich; Simone Pötzsch; Bettina Blaumeiser; Susanne Moebus; Michael Krawczak; Stefan Schreiber; Thomas Meitinger; Hans-Erich Wichmann; Regine P Steegers-Theunissen; Franz-Josef Kramer; Sven Cichon; Peter Propping; Thomas F Wienker; Michael Knapp; Michele Rubini; Peter A Mossey; Per Hoffmann; Markus M Nöthen Journal: Nat Genet Date: 2009-12-20 Impact factor: 38.330
Authors: S Allerstorfer; G Sonvilla; H Fischer; S Spiegl-Kreinecker; C Gauglhofer; U Setinek; T Czech; C Marosi; J Buchroithner; J Pichler; R Silye; T Mohr; K Holzmann; B Grasl-Kraupp; B Marian; M Grusch; J Fischer; M Micksche; W Berger Journal: Oncogene Date: 2008-03-24 Impact factor: 9.867
Authors: Christina Drevinge; Knut T Dalen; Maria Nastase Mannila; Margareta Scharin Täng; Marcus Ståhlman; Martina Klevstig; Annika Lundqvist; Ismena Mardani; Fred Haugen; Per Fogelstrand; Martin Adiels; Jorge Asin-Cayuela; Charlotte Ekestam; Jesper R Gådin; Yun K Lee; Hilde Nebb; Sara Svedlund; Bengt R Johansson; Lillemor Mattsson Hultén; Stefano Romeo; Björn Redfors; Elmir Omerovic; Max Levin; Li-Ming Gan; Per Eriksson; Linda Andersson; Ewa Ehrenborg; Alan R Kimmel; Jan Borén; Malin C Levin Journal: Int J Cardiol Date: 2016-06-16 Impact factor: 4.164
Authors: Innocent G Asiimwe; Eunice J Zhang; Rostam Osanlou; Amanda Krause; Chrisly Dillon; Guilherme Suarez-Kurtz; Honghong Zhang; Jamila A Perini; Jessicca Y Renta; Jorge Duconge; Larisa H Cavallari; Leiliane R Marcatto; Mark T Beasly; Minoli A Perera; Nita A Limdi; Paulo C J L Santos; Stephen E Kimmel; Steven A Lubitz; Stuart A Scott; Vivian K Kawai; Andrea L Jorgensen; Munir Pirmohamed Journal: Clin Pharmacol Ther Date: 2020-01-28 Impact factor: 6.875
Authors: Markus Gulilat; Tyler Lamb; Wendy A Teft; Jian Wang; Jacqueline S Dron; John F Robinson; Rommel G Tirona; Robert A Hegele; Richard B Kim; Ute I Schwarz Journal: BMC Med Genomics Date: 2019-06-03 Impact factor: 3.063
Authors: Cristina Gallego-Fabrega; Elena Muiño; Jara Cárcel-Márquez; Laia Llucià-Carol; Miquel Lledós; Jesús M Martín-Campos; Natalia Cullell; Israel Fernández-Cadenas Journal: Int J Mol Sci Date: 2022-06-20 Impact factor: 6.208